Display options
Cite
Alpern JD, Leventhal TM, Bahr NC. Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program. J Health Care Poor Underserved. 2020;31(3):1037-1043doi: 10.1353/hpu.2020.0077.
Alpern, J. D., Leventhal, T. M., & Bahr, N. C. (2020). Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program. Journal of health care for the poor and underserved, 31(3), 1037-1043. https://doi.org/10.1353/hpu.2020.0077
Alpern, Jonathan D, et al. "Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program." Journal of health care for the poor and underserved vol. 31,3 (2020): 1037-1043. doi: https://doi.org/10.1353/hpu.2020.0077
Alpern JD, Leventhal TM, Bahr NC. Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program. J Health Care Poor Underserved. 2020;31(3):1037-1043. doi: 10.1353/hpu.2020.0077. PMID: 33416677; PMCID: PMC7830854.
Copy Download .nbib Format: NLM
Share it on

J Health Care Poor Underserved. 2020;31(3):1037-1043. doi: 10.1353/hpu.2020.0077.

Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program.

Journal of health care for the poor and underserved

Jonathan D Alpern, Thomas M Leventhal, Nathan C Bahr

PMID: 33416677 PMCID: PMC7830854 DOI: 10.1353/hpu.2020.0077

Abstract

Chronic hepatitis B infection is common in the United States, yet only a minority of eligible people are screened, vaccinated, and receive treatment. The Ryan White HIV/AIDS program has been a key tool for ensuring that socioeconomically disadvantaged HIV-infected patients have access to care. Many of the same disease and patient attributes that make the Ryan White program necessary and effective for HIV exist in chronic hepatitis B. Thus, we believe that the current Ryan White program should be expanded to care for people with hepatitis B under similar regulations. Considering recent changes proposed to the health insurance marketplace, policymakers should strongly consider inclusion of chronic hepatitis B in the safety-net Ryan White Program.

References

  1. Dig Dis Sci. 2011 Nov;56(11):3163-71 - PubMed
  2. J Viral Hepat. 2017 Jul;24(7):526-540 - PubMed
  3. Clin Infect Dis. 2016 Jan 1;62(1):90-98 - PubMed
  4. Ann Intern Med. 2017 Dec 5;167(11):794-804 - PubMed
  5. Clin Infect Dis. 2011 Jun;52(11):1294-306 - PubMed
  6. Ann Intern Med. 2018 Jun 19;168(12):902 - PubMed
  7. Hepatology. 2012 Aug;56(2):422-33 - PubMed
  8. Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):29-32 - PubMed
  9. Hepatology. 2007 Oct;46(4):1034-40 - PubMed
  10. J Multidiscip Healthc. 2015 Jan 06;8:1-9 - PubMed
  11. Open Forum Infect Dis. 2018 Dec 26;6(1):ofy353 - PubMed
  12. Clin Infect Dis. 2019 Mar 5;68(6):956-963 - PubMed
  13. MMWR Morb Mortal Wkly Rep. 2018 May 18;67(19):541-546 - PubMed
  14. Am J Public Health. 2018 Nov;108(S4):S327-S335 - PubMed
  15. Health Aff (Millwood). 2011 Oct;30(10):1974-83 - PubMed

MeSH terms

Publication Types

Grant support